ResMed Inc. Q2 2026 Earnings Recap

RMD Q2 2026 January 30, 2026

ResMed achieved strong second-quarter results for fiscal year 2026, marked by 11% revenue growth and significant margin expansion, driven by innovation in digital health solutions.

Earnings Per Share Beat

$2.81 vs $2.74 est.

+2.6% surprise

Revenue Beat

1422808000 vs 1400545000 est.

+1.6% surprise

Market Reaction

1-Day -1.38%

5-Day +5.16%

30-Day -0.79%

Key Takeaways

Revenue increased by 11%, with 9% growth on a constant currency basis, reflecting robust demand across product categories.
Operating margin improved by 310 basis points year-over-year, with GAAP EPS rising by 16%.
Global devices revenue grew high single-digits, while masks and accessories experienced double-digit growth, aided by strategic market initiatives.
Successful launch of new fabric masks enhances ResMed's competitive edge in the market.
Continued strong cash flow and a solid balance sheet position the company well for future growth and shareholder returns.

This summary was generated by AI from the official earnings call transcript and is provided for informational purposes only. It does not constitute financial advice. For the complete transcript and financial data, visit RMD on AllInvestView.